Increasing incidence of chronic diseases is expected to drive the growth of India Active Pharmaceutical Ingredients market during the forecast period.
According to TechSci Research report, “India Active Pharmaceutical Ingredients Market By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Diseases, Skin Infections, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections, Others), By Form (Tablet, Capsule, Injection, Others), By Route of Administration (Oral v/s Intravenous), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India Active Pharmaceutical Ingredients market is expected to grow at a formidable rate during the forecast period on account of surging drug research and development.
Rising prevalence of chronic ailments such as CVDs, arthritis, and diabetes, coupled with increasing count of infectious diseases like influenza, hepatitis, and coronavirus in the country are bolstering the demand for drugs and medications. In addition to this, growing importance of generics is further expected to fuel the market growth through FY2026. Also, mounting incidence of obesity in India is estimated to drive the demand for APIs. However, unfavorable drug price control policies across various countries can restrict the market growth over the next few years. Moreover, high manufacturing costs of APIs can further hinder the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread through XX Pages and an in-depth TOC on “India Active Pharmaceutical Ingredients Market”
https://www.techsciresearch.com/report/india-active-pharmaceutical-ingredients-market/7277.html
The India Active Pharmaceutical Ingredient market is segmented based on drug type, source, distribution channel, therapeutic application, form, route of administration, end user, company, and region. Based on route of administration, the market can be fragmented into oral v/s intravenous. The oral route of administration segment is expected to dominate the market in the forthcoming years on account of its versatility to accommodate various types of drugs.
Moreover, the oral route is the most convenient and usually the safest, thereby positively influencing the segmental growth in the upcoming years. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. The in-house segment dominated the market until FY2020 as most of the leading companies focus on in house production. Contract manufacturing organizations segment is expected to witness significant growth in the market as it saves cost and maximizes profit. Besides, high growth in number of contract manufacturers is further contributing to its fast growing CAGR.
Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals Industries Ltd., Taj Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Fresenius Kabi India Pvt. Ltd. and others are some of the leading players operating in India Active Pharmaceutical Ingredient market. Companies operating in the market are using organic strategies such as product launches, mergers and acquisitions and research collaborations to boost their share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7277
Customers can also request for 10% free customization on this report.
“India Active Pharmaceutical Ingredients market is expected to witness high growth during the forecast period which is attributable to increasing uptake of biopharmaceuticals. Additionally, major market players are focusing on strategic collaborations to commercialize their newly developed drugs. This is further expected to create lucrative opportunities for the market growth of India Active Pharmaceutical Ingredient market over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“India Active Pharmaceutical Ingredients Market By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Diseases, Skin Infections, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections, Others), By Form (Tablet, Capsule, Injection, Others), By Route of administration (Oral v/s Intravenous), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India Active Pharmaceutical Ingredients market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India Active Pharmaceutical Ingredients market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]